Education
About Us
Working with TipRanks
Follow Us
Lifestance Health Group (LFST)
NASDAQ:LFST
Total Valuation
Lifestance Health Group has a market cap or net worth of $1.70B. The enterprise value is $2.28B.
Market Cap$1.70B
Enterprise Value$2.28B
Share Statistics
Lifestance Health Group has 388,936,400 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding388,936,400
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Lifestance Health Group’s return on equity (ROE) is -0.04 and return on invested capital (ROIC) is -1.62%.
Return on Equity (ROE)-0.04
Return on Assets (ROA)-0.03
Return on Invested Capital (ROIC)-1.62%
Return on Capital Employed (ROCE)-0.02
Revenue Per Employee166.02K
Profits Per Employee-7.62K
Employee Count7,535
Asset Turnover0.59
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Lifestance Health Group is ―. Lifestance Health Group’s PEG ratio is ―.
PE Ratio―
PS Ratio0.00
PB Ratio0.00
Price to Fair Value1.93
Price to FCF0.00
Price to Operating Cash Flow12.68
PEG Ratio―
Income Statement
In the last 12 months, Lifestance Health Group had revenue of 1.25B and earned -57.44M in profits. Earnings per share was -0.15.
Revenue1.25B
Gross Profit402.40M
Operating Income-31.61M
Pretax Income-57.61M
Net Income-57.44M
EBITDA39.87M
Earnings Per Share (EPS)-0.15
Cash Flow
In the last 12 months, operating cash flow was 2.40M and capital expenditures -8.64M, giving a free cash flow of -6.25M billion.
Operating Cash Flow2.40M
Free Cash Flow-6.25M
Free Cash Flow per Share-0.02
Dividends & Yields
Lifestance Health Group pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.91
52-Week Price Change-16.91%
50-Day Moving Average4.82
200-Day Moving Average6.55
Relative Strength Index (RSI)51.31
Average Volume (3m)2.44M
Important Dates
Lifestance Health Group upcoming earnings date is Nov 5, 2025, After Close (Confirmed).
Last Earnings DateAug 7, 2025
Next Earnings DateNov 5, 2025
Ex-Dividend Date―
Financial Position
Lifestance Health Group as a current ratio of 1.37, with Debt / Equity ratio of 13.50%
Current Ratio1.37
Quick Ratio1.37
Debt to Market Cap0.10
Net Debt to EBITDA8.29
Interest Coverage Ratio-1.19
Taxes
In the past 12 months, Lifestance Health Group has paid -170.00K in taxes.
Income Tax-170.00K
Effective Tax Rate<0.01
Enterprise Valuation
Lifestance Health Group EV to EBITDA ratio is 78.37, with an EV/FCF ratio of 36.47.
EV to Sales2.50
EV to EBITDA78.37
EV to Free Cash Flow36.47
EV to Operating Cash Flow29.13
Balance Sheet
Lifestance Health Group has $134.34M in cash and marketable securities with $473.01M in debt, giving a net cash position of $338.68M billion.
Cash & Marketable Securities$134.34M
Total Debt$473.01M
Net Cash$338.68M
Net Cash Per Share$0.87
Tangible Book Value Per Share-$0.10
Margins
Gross margin is 29.93%, with operating margin of -2.53%, and net profit margin of -4.59%.
Gross Margin29.93%
Operating Margin-2.53%
Pretax Margin-4.61%
Net Profit Margin-4.59%
EBITDA Margin3.19%
EBIT Margin-2.48%
Analyst Forecast
The average price target for Lifestance Health Group is $8.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$8.00
Price Target Upside75.05% Upside
Analyst ConsensusModerate Buy
Analyst Count7
Revenue Growth Forecast13.86%
EPS Growth Forecast89.49%